Defective platelet aggregation in polycythaemia vera is not caused by impaired calcium signaling, phospholipase D activation or decreased amounts of focal adhesion proteins

European Journal of Haematology

Volumn 65, Issue 5, 2000, Pages 322-330

  Le Blanc, Katarina ^a,c   Berg, Anders ^a   Palmblad, Jan ^a   Samuelsson, Jan ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Calcium; Phospholipase D; Phosphorylation; Platelet; Polycythaemia vera; Tyrosine

Indexed keywords

CALCIUM ION; FIBRINOGEN; FIBRINOGEN RECEPTOR; FOCAL ADHESION KINASE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE D; PHOSPHOLIPID; PROTEIN TYROSINE KINASE; THROMBIN; THROMBOCYTE ACTIVATING FACTOR;

ADULT; AGED; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CELL LYSATE; CELL MEMBRANE; CLINICAL ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MALE; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CALCIUM; CALCIUM SIGNALING; ENZYME PRECURSORS; FEMALE; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; GRB2 ADAPTOR PROTEIN; HUMANS; INTEGRIN BETA3; INTEGRINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRAMOLECULAR TRANSFERASES; KINETICS; MALE; MIDDLE AGED; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPASE D; PHOSPHORYLATION; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; POLYCYTHEMIA VERA; PROTEIN-TYROSINE KINASES; PROTEINS; RHOA GTP-BINDING PROTEIN; TYROSINE;

EID: 0033735217     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.065005322.x     Document Type: Article

References (50)

1. Polycythemia vera: Stem cell and probable clonal origin of the disease
2. Clonality in myeloproliferative disorders
3. Bleeding and thrombosis in the myeloproliferative disorders
4. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders
5. Bleeding and thrombosis in myeloproliferative disorders: Mechanisms and treatment
6. 3-independent mechanism
7. Integrin signaling: The platelet paradigm
8. Stimulus-specific defect in oxidative metabolism of polymorphonuclear granulocytes in polycythemia vera
9. Further studies of the defective stimulus-response coupling for the oxidative burst in neutrophils in polycythemia vera
10. Studies of neutrophil and monocyte oxidative responses in polycythemia vera and related myeloproliferative disorders
11. Superoxide anion production and phospholipase D generated mediation of diacylglycerol are subnormal after N-formyl-methionyl-leucyl-phenylalanine stimulation of polymorphonuclear granulocytes in polycythemia vera
12. Stimulus specific defect in platelet aggregation in polycythemia vera
13. Defective aggregation of platelets in polycythemia vera is caused by an impaired binding of fibrinogen due to a lower number of GPIIb/IIIa receptors
14. Diagnosis and classification of the polycythemias
15. 2+ indicators with greatly improved fluorescence capacities
16. Measurement of intracellular calcium with (Quin2)
17. The formation of phosphatidylglycerol and other phospholipids by the transferase activity of phospholipase D
18. Activation of phospholipase D by chemotactic peptide in HL-60 granulocytes
19. Phosphatidylethanol formation in human platelets: Evidence for thrombin-induced activation of phospholipase D
20. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
21. 2+-ATPases
22. Release of choline metabolites from human platelets: Evidence for activation of phospholipase D and of phosphatidylcholine-specific phospholipase C
23. 2+ activates phospholipase D in human platelets
24. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors
25. Abnormalities of platelet function in patients with polycythemia vera
26. Alterations in thrombin-induced protein tyrosine phosphorylation of platelets from patients with chronic myelogenous leukemia
27. The Fc-receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen
28. Platelet function in patients with high platelet counts
29. Qualitative platelet defects in chronic myeloproliferative disorders: Evidence for reduced ATP secretion
30. Platelet function in myeloproliferative disorders: Characterization and sequential studies show multiple platelet abnormalities, and change with time
31. Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders
32. Rho: A connection between membrane receptor signaling and the cytoskeleton
33. Platelets in the myeloproliferative syndrome
34. Chronic myeloproliferative disorders: Improved platelet aggregation following venesection
35. Platelet adenine nucleotides and arachidonic acid metabolism in the myeloproliferative disorders
36. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders
37. Evidence for a platelet membrane defect in the myeloproliferative syndromes
38. In vivo platelet release in myeloproliferative disorders
39. Increased thromboxane biosynthesis in patients with polycythemia vera: Evidence for aspirin-suppressible platelet activation in vivo
40. Defective platelet aggregation induced by platelet activating factor in myeloproliferative disorders: Deficiency of an aspirin-independent mechanism?
41. Blood platelet calcium content and aggregation behavior in myeloproliferative disorders
42. Low intracellular calcium concentration in the platelets after stimulation in patients with myeloproliferative disorders
43. Deficient elevation of the cytoplasmic calcium ion concentration by epinephrine in epinephrine-insensitive platelets of patients with myeloproliferative disorders
44. Inositol-1,4,5-trisphosphate induced release of sequestered from highly purified human platelet intracellular membranes
45. 3
46. Phosphatidylcholine hydrolysis by phospholipase D determines phosphatidate and diglyceride levels in chemotactic peptide-stimulated neutrophils. Involvement of phosphatidate phosphohydrolase in signal transduction
47. Phospholipid determination in platelets, plasma and red cells of patients with chronic myeloproliferative disorders
48. Phospholipase activation and secretion: Evidence that PLA2, PLC and PLD are not essential to exocytosis
49. Impaired expression of the thrombopoietin receptor by platelets from patient with polycythemia vera
50. Signal transduction in platelets from patients with polycythemia vera